MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLTX is expected to report earnings to rise 5.40% to -75 cents per share on May 08

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q1'25

Est.

$-0.76

Q4'24

Missed

by $0.12

Q3'24

Missed

by $0.12

Q2'24

Missed

by $0.11

Q1'24

Missed

by $0.02

The last earnings report on February 26 showed earnings per share of -72 cents, missing the estimate of -60 cents. With 142.05K shares outstanding, the current market capitalization sits at 2.50B.

View a ticker or compare two or three

Compare

MLTX